Skip to main content

Volume 17 Supplement 1

Abstracts from “Chronic viral infection and cancer, openings for vaccines” virtual symposium of the TechVac Network

Meeting abstracts

Symposium was sponsored by Riga Stradins University (RSU), Riga, Latvia; Peoples Friendship University of Russia (RUDN University); R&D companies "BD Biosciences" and "Helicon"; research journals "Infectious Agents and Cancer" (BMC, Spinger Nature) and "Cancers" (MDPI, Bazel) and by the Virtual Mobility Grant of the European Network of Vaccine Adjuvants ENOVA COST Action CA16231 to M. Isaguliants at RSU, Riga, Latvia.

VirtualDecember 16-17, 2021

Edited by Maria Isaguliants, Natalia Petrakova and Franco Buonaguro.

Annual Journal Metrics

  • 2022 Citation Impact
    3.7 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.040 - SNIP (Source Normalized Impact per Paper)
    0.583 - SJR (SCImago Journal Rank)

    2022 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    115 days submission to accept (Median)

    2022 Usage 
    1,550 Altmetric mentions

What is trending?


               Click here to see which articles published in Infectious Agents and Cancer have been shared the most in the past three months.